The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress?
Abstract
BACKGROUND: Adrenocortical carcinoma (ACC), a rare and aggressive malignancy, accounts for up to 14% of adrenal incidentalomas. The only chance of cure for ACC is diagnosis at an early stage; therefore, a main indication for adrenalectomy in patients with adrenal incidentaloma has been the potential risk of ACC. Recent studies suggest that this has led to earlier stage of ACC at diagnosis, more curative operations, and better survival. METHODS: We analyzed data on ACC from The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database. Four equal time quartiles (1973-1979, 1980-1986, 1987-1993, and 1994-2000) were compared for changes in demographics, pathology, treatment, and cause-specific mortality. RESULTS: The average age was 51.2 years (range: 1-97), and 45.9% of patients were men. The average tumor size was 12 cm (range: 2-36 cm), and only 4.2% were < or = 6 cm. Most (88%) patients had surgical resection of their tumor, and external beam radiotherapy was used in only 12% of patients. Between the time quartiles compared (as well as annually), there was no significant difference at presentation in age at diagnosis, sex, race/ethnicity, tumor size, tumor grade, the frequency of distant metastasis, and overall TNM stage. Low tumor grade, lower stage of ACC, later time quartile, and surgical resection were associated with a lower cause-specific mortality by univariate analysis (P < or = 0.002) and by multivariate analysis (P < or = 0.031). CONCLUSIONS: Although adrenal incidentalomas have become a common indication for adrenalectomy, this has not resulted in patients with ACC being diagnosed earlier or treated at a lower stage of disease at the national level. The most important predictors of survival in these patients are tumor grade, tumor stage, and surgical resection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Surveillance, Epidemiology, and End Results (SEER) database provides an estimation of incidence of approximately 0.72 per million cases per year leading to 0.2% of all cancer deaths in the United States (4).”
From Adrenocortical carcinoma (2014) · cites this paper as [4]
In the citing paper
“In the United States, it is used in approximately 10% of cases, according to analyses of both the National Cancer Data Base and the SEER program (4, 11, 90).”
From Adrenocortical carcinoma (2014) · cites this paper as [4]
Citations
Cites
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic, A., Ghossein, R. A., Hoos, A., Nissan, A., Marshall, D., Dudas, M. E., Cordon‐Cardo, C., Jaques, D. P., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.4.941 · Cited by 312
de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261
Survival Variability by Race and Ethnicity in Childhood Acute Lymphoblastic Leukemia
Kadan‐Lottick, N. S. (2003) · JAMA · doi:10.1001/jama.290.15.2008 · Cited by 238
Management of adrenocortical carcinoma
Allolio, B., Hahner, S., Weismann, D., & Fassnacht, M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01881.x · Cited by 214
Kendrick, M. L. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.5.543 · Cited by 140
Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Harrison, L. E. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.2.181 · Cited by 117
Research works printed but not linked: 1
- 10.1200/JCO.20.4.941 · DOI
Cited by
Sorted by citations
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Faßnacht, M., Terzolo, M., Allolio, B., Baudin, É., Haak, H. R., Berruti, A., Welin, S., Schade‐Brittinger, C., Lacroix, A., Jarząb, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200966 · Cited by 874
Integrated genomic characterization of adrenocortical carcinoma
Assié, G., Letouzé, E., Fassnacht, M., Jouinot, A., Luscap, W., Barreau, O., Omeiri, H., Rodriguez, S., Perlemoine, K., René-Corail, F., et al. (2014) · Nature Genetics · doi:10.1038/ng.2953 · Cited by 732
Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Golden, S. H., Robinson, K. A., Saldanha, I., Anton, B., & Ladenson, P. W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2291 · Cited by 542
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C. (2008) · Cancer · doi:10.1002/cncr.23886 · Cited by 493
Self-citationNiclosamide: Beyond an antihelminthic drug
Chen, W., Mook, R. A., Premont, R. T., & Wang, J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.04.001 · Cited by 446
Faßnacht, M., Assié, G., Baudin, É., Eisenhofer, G., de la Fouchardière, C., Haak, H. R., de Krijger, R. R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 446
Update in Adrenocortical Carcinoma
Faßnacht, M., Kroiß, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414
Adrenocortical carcinoma: a clinician’s update
Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P. I., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 385
Clinical management of adrenocortical carcinoma
Fassnacht, M., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.008 · Cited by 349
Kerkhofs, T. M. A., Verhoeven, R. H. A., van der Zwan, J. M., Dieleman, J. P., Kerstens, M. N., Links, T. P., van de Poll-Franse, L. V., & Haak, H. R. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.034 · Cited by 343
American Association of Endocrine Surgeons Guidelines for Adrenalectomy
Yip, L., Duh, Q., Wachtel, H., Jiménez, C., Sturgeon, C., Lee, C. Y., Velázquez‐Fernández, D., Berber, E., Hammer, G. D., Bancos, I., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.3544 · Cited by 273
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
Libé, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00045 · Cited by 233
Gaujoux, S., Mihai, R., Carnaille, B. M. L., Dousset, B. E., Fiori, C., Porpiglia, F., Hellman, P., Iacobone, M., Kraimps, J. L., Donatini, G., et al. (2017) · British journal of surgery · doi:10.1002/bjs.10414 · Cited by 226
Giovanni Lughezzani, A., Sun, M., Perrotte, P., Claudio Jeldres, A., Alasker, A., Hendrik Isbarn, A., Budäus, L., Shariat, S. F., Guazzoni, G. F., Montorsi, F., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.007 · Cited by 214
Adrenocortical carcinoma is a Lynch syndrome-associated cancer
Raymond, V. M., Everett, J. N., Furtado, L. V., Gustafson, S. L., Jungbluth, C. R., Gruber, S. B., Hammer, G. D., Stoffel, E. M., Greenson, J. K., Giordano, T. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.0988 · Cited by 208
Development of adrenal cortex zonation
Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial
Kroiss, M., Quinkler, M., Johanssen, S., van Erp, N. P., Lankheet, N., Pöllinger, A., Laubner, K., Strasburger, C. J., Hahner, S., Müller, H.-H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1419 · Cited by 175
Tourneau, C. L., Hoimes, C. J., Zarwan, C., Wong, D. J. L., Bauer, S., Claus, R., Wermke, M., Hariharan, S., von Heydebreck, A., Kasturi, V., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0424-9 · Cited by 173
The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study
Sharma, E., Dahal, S., Sharma, P., Bhandari, A., Gupta, V., Amgai, B., & Dahal, S. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3503w · Cited by 161
Faßnacht, M., Johanssen, S., Fenske, W., Weismann, D., Agha, A., Beuschlein, F., Führer, D., Jurowich, C. F., Quinkler, M. O., Petersenn, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0803 · Cited by 156
Veytsman, I. G., Nieman, L. K., & Fojo, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2775 · Cited by 147
Naing, A., LoRusso, P. M., Fu, S., Hong, D. S., Chen, H. X., Doyle, L. A., Phan, A. T., Habra, M. A., & Kurzrock, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.46 · Cited by 134
Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.4516 · Cited by 131
The Occurrence of Rare Cancers in U.S. Adults, 1995–2004
Greenlee, R. T., Goodman, M. T., Lynch, C. F., Platz, C. E., Havener, L. A., & Howe, H. L. (2010) · Public Health Reports · doi:10.1177/003335491012500106 · Cited by 131
Adjuvant and definitive radiotherapy for adrenocortical carcinoma
Sabolch, A., Feng, M., Griffith, K., Hammer, G., Doherty, G., & Ben-Josef, E. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.04.030 · Cited by 115
Identification of Biomarkers of Adrenocortical Carcinoma Using Genomewide Gene Expression Profiling
Fernandez-Ranvier, G. G. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.9.841 · Cited by 116
Contemporary Management of Adrenocortical Carcinoma
Laurent Zini, A., Porpiglia, F., & Faßnacht, M. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.062 · Cited by 111
Management of adrenal cancer: a 2013 update
Terzolo, M., Daffara, F., Ardito, A., Zaggia, B., Basile, V., Ferrari, L., & Berruti, A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0049-2 · Cited by 109
Raymond, V. M., Else, T., Everett, J. N., Long, J. M., Gruber, S. B., & Hammer, G. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2198 · Cited by 105
Habra, M. A., Ejaz, S., Feng, L., Das, P., Deniz, F., Grubbs, E. G., Phan, A., Waguespack, S. G., Ayala-Ramirez, M., Jimenez, C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2367 · Cited by 101
Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes
Margonis, G. A., Kim, Y., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4803-x · Cited by 96
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
Satoh, K., Zhang, L., Zhang, Y., Chelluri, R. R., Boufraqech, M., Nilubol, N., Patel, D., Shen, M., & Kebebew, E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2256 · Cited by 96
Elhassan, Y. S., Altieri, B., Berhane, S., Cosentini, D., Calabrese, A., Haissaguerre, M., Kaštelan, D., Fragoso, M. C. B. V., Bertherat, J. Y., Ghuzlan, A. A., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0510 · Cited by 95
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
Fay, A. P., Signoretti, S., Callea, M., Teló, G. H., McKay, R. R., Song, J., Carvo, I., Lampron, M. E., Kaymakcalan, M. D., Poli‐de‐Figueiredo, C. E., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0047-3 · Cited by 94
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma
Chortis, V., Bancos, I., Nijman, T., Gilligan, L. C., Taylor, A. E., Ronchi, C. L., O’Reilly, M. W., Schreiner, J., Asia, M., Riester, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz141 · Cited by 93
TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma
Jain, M., Zhang, L., He, M., Zhang, Y., Shen, M., & Kebebew, E. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0403 · Cited by 87
New perspectives for mitotane treatment of adrenocortical carcinoma
Puglisi, S., Calabrese, A., Basile, V., Pia, A., Reimondo, G., Perotti, P., & Terzolo, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101415 · Cited by 91
Postlewait, L. M., Ethun, C. G., Tran, T. B., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., Phay, J. E., et al. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.12.013 · Cited by 87
Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Schweitzer, S., Kunz, M., Kurlbaum, M., Vey, J., Kendl, S., Deutschbein, T., Hahner, S., Fassnacht, M., Dandekar, T., & Kroiss, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0782 · Cited by 85
Recommendation for standardized surgical management of primary adrenocortical carcinoma
Gaujoux, S., & Brennan, M. F. (2012) · Surgery · doi:10.1016/j.surg.2011.09.030 · Cited by 84
Management of Adrenocortical Carcinoma
Jasim, S., & Habra, M. A. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0773-7 · Cited by 82
Sabolch, A. N., Else, T., Griffith, K. A., Ben‐Josef, E., Williams, A., Miller, B. S., Worden, F. P., Hammer, G. D., & Jolly, S. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.007 · Cited by 81
Bluemel, C., Hahner, S., Heinze, B., Faßnacht, M., Kroiß, M., Bley, T. A., Wester, H., Kropf, S., Lapa, C., Schirbel, A., et al. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001435 · Cited by 81
Genetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80
Adrenocortical carcinoma survival rates correlated to genomic copy number variants
Stephan, E. A., Chung, T., Grant, C. S., Kim, S., Hoff, D. D. V., Trent, J. M., & Demeure, M. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0267 · Cited by 80
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database
Tella, S. H., Kommalapati, A., Yaturu, S., & Kebebew, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00918 · Cited by 80
Jin, Y., Wang, Z., He, D., Zhu, Y., Hu, X., Gong, L., Xiao, M., Chen, X., Cheng, Y., & Cao, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637933 · Cited by 75
Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention
Shin, W. J., Zabel, B. A., & Pachynski, R. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02772 · Cited by 75
Aron, D. C., Terzolo, M., & Cawood, T. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.06.012 · Cited by 74
Role of microRNAs in endocrine cancer metastasis
Lima, C. R., Gomes, C. C., & dos Santos, M. F. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.015 · Cited by 69
Adrenocortical carcinoma: The management of metastatic disease
Fay, A. P., Elfiky, A. A., Teló, G. H., McKay, R. R., Kaymakcalan, M. D., Nguyen, P. L., Vaidya, A., Ruan, D. T., Joaquim Bellmunt, B., & Choueiri, T. K. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.05.009 · Cited by 69
Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified?
Gaujoux, S., Al‐Ahmadie, H. A., Allen, P. J., Gönen, M., Shia, J., D'Angelica, M. I., DeMatteo, R. P., Fong, Y., Blumgart, L. H., & Jarnagin, W. R. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2358-7 · Cited by 68
Huang, Y., Li, D., Wang, L., Su, X., & Tang, X.-B. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03277-y · Cited by 66
Baudin, É. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.03.001 · Cited by 66
Pharmacological profile and effects of mitotane in adrenocortical carcinoma
Corso, C. R., Acco, A., Bach, C., Bonatto, S. J. R., de Figueiredo, B. C., & de Souza, L. M. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14721 · Cited by 69
Laparoscopic radical adrenalectomy for cancer: long-term outcomes
McCauley, L. R., & Nguyen, M. M. (2008) · Current Opinion in Urology · doi:10.1097/mou.0b013e3282f3e6d2 · Cited by 65
Kerkhofs, T. M. A., Verhoeven, R. H. A., Bonjer, H. J., van Dijkum, E. J. M. N., Vriens, M. R., de Vries, J., van Eijck, C. H. J., Bonsing, B. A., van de Poll-Franse, L. V., Haak, H. R., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0142 · Cited by 65
Ozimek, A., Diebold, J., Linke, R., Heyn, J., Hallfeldt, K. K. J., & Mussack, T. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-035 · Cited by 63
Smith, D. C., Kroiß, M., Kebebew, E., Habra, M. A., Chugh, R. K., Schneider, B. J., Faßnacht, M., Jafarinasabian, P., Ijzerman, M. M., Lin, V. H., et al. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00899-1 · Cited by 61
Jouinot, A., & Bertherat, J. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0027 · Cited by 61
Calabrese, A., Basile, V., Puglisi, S., Perotti, P., Pia, A., Saba, L., Berchialla, P., Porpiglia, F., Veltri, A., Volante, M., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0923 · Cited by 59
Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence
Amini, N., Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4810-y · Cited by 59
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 61
KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer
Jain, M., Zhang, L., Patterson, E. E., & Kebebew, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026866 · Cited by 58
Deficits in the Management of Patients With Adrenocortical Carcinoma in Germany
Johanssen, S., Hahner, S., Saeger, W., Quinkler, M. O., Beuschlein, F., Dralle, H., Haaf, M., Kroiß, M., Jurowich, C. F., Langer, P., et al. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0885 · Cited by 60
Ahmed, A. A., Thomas, A. J., Ganeshan, D., Blair, K. J., Lall, C. G., Lee, J. T., Morshid, A. I., Habra, M. A., & Elsayes, K. M. (2020) · Abdominal Radiology · doi:10.1007/s00261-019-02371-y · Cited by 59
Shariq, O. A., & McKenzie, T. J. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211033103 · Cited by 63
Diagnosis, treatment and outcome of adrenocortical cancer
Mihai, R. (2015) · British journal of surgery · doi:10.1002/bjs.9743 · Cited by 56
Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease
Livhits, M. J., Li, N., Yeh, M. W., & Harari, A. (2014) · Surgery · doi:10.1016/j.surg.2014.08.047 · Cited by 55
Surgical Resection of Synchronously Metastatic Adrenocortical Cancer
Dy, B. M., Strajina, V., Cayo, A. K., Richards, M. L., Farley, D. R., Grant, C. S., Harmsen, W. S., Evans, D. B., Grubbs, E. G., Bible, K. C., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3944-7 · Cited by 55
Management of adrenal tumors in pregnancy.
Eschler, D. C., Kogekar, N., & Pessah-Pollack, R. (2015) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2015.02.006 · Cited by 58
The Adrenal Mass: Correlation of Histopathology with Imaging
Yip, L., TUBLIN, M. E., Falcone, J. L., Nordman, C. R., Stang, M. T., Ogilvie, J. B., Carty, S. E., & Yim, J. H. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0829-2 · Cited by 54
Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
Kostiainen, I., Hakaste, L., Kejo, P., Parviainen, H., Laine, T., Löyttyniemi, E., Pennanen, M., Arola, J. T., Haglund, C. H., Heiskanen, I., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01918-9 · Cited by 53
Chandrasekar, T., Goldberg, H., Klaassen, Z. W. A., Wallis, C. J. D., Woon, D. T. S., Herrera-Caceres, J. O., Kulkarni, G. S., & Fleshner, N. E. (2018) · Cancer · doi:10.1002/cncr.31916 · Cited by 51
Pathobiology and genetics of adrenocortical carcinoma
Pittaway, J. F. H., & Guasti, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0122 · Cited by 49
Wanis, K. N., & Kanthan, R. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0527-4 · Cited by 49
Current management options for recurrent adrenocortical carcinoma
Sidhu, S. B., Glover, A. R., Ip, Zhao, J., Soon, & Robinson (2013) · OncoTargets and Therapy · doi:10.2147/ott.s34956 · Cited by 46
Mihai, R., Iacobone, M., Makay, Ö., Moreno, P., Frilling, A., Kraimps, J., Soriano, A., Villar, J. M., Barczyński, M., Durán, M., et al. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0876-6 · Cited by 46
Role of Radiotherapy in Adrenocortical Carcinoma
Ho, J., Türkbey, B., Edgerly, M., Alimchandani, M., Quezado, M., Camphausen, K. A., Fojo, T., & Kaushal, A. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31829e3221 · Cited by 44
Asare, E. A., Wang, T. S., Winchester, D. P., Mallin, K., Kebebew, E., & Sturgeon, C. (2014) · Surgery · doi:10.1016/j.surg.2014.08.018 · Cited by 45
Puglisi, S., Calabrese, A., Ferraù, F., Violi, M. A., Laganà, M., Grisanti, S., Ceccato, F., Scaroni, C. M., Dalmazi, G. D., Stigliano, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad199 · Cited by 44
Actual 10‐year survivors following resection of adrenocortical carcinoma
Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., Glenn, J. A., Phay, J. E., Keplinger, K. M., Fields, R. C., Jin, L. X., et al. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24439 · Cited by 44
Bagante, F., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., Phay, J. E., Keplinger, K. M., et al. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23982 · Cited by 43
Pathway Implications of Aberrant Global Methylation in Adrenocortical Cancer
Legendre, C., Demeure, M. J., Whitsett, T. G., Gooden, G. C., Bussey, K. J., Jung, S., Tembe, W., Kim, S., & Salhia, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150629 · Cited by 43
Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way
Cunha, L. L., Marcello, M. A., Rocha‐Santos, V., & Ward, L. S. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0222 · Cited by 44
Developing treatment for adrenocortical carcinoma
Kerkhofs, T. M. A., Ettaieb, M. H. T., Hermsen, I. G. C., & Haak, H. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0318 · Cited by 41
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options
Puglisi, S., Perotti, P., Cosentini, D., Roca, E., Basile, V., Berruti, A., & Terzolo, M. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1510325 · Cited by 42
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
Lebastchi, A. H., Kunstman, J. W., & Carling, T. (2012) · Journal of Oncology · doi:10.1155/2012/234726 · Cited by 39
Surgery for adrenocortical carcinoma: When and how?
Sinclair, T. J., Gillis, A., Alobuia, W. M., Wild, H. B. H., & Kebebew, E. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101408 · Cited by 42
Tian, X., Xu, W., Wang, Y., Anwaier, A., Wang, H., Wan, F., Zhu, Y., Cao, D., Shi, G., Zhu, Y., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1784529 · Cited by 41
Adrenal MRI: Techniques and clinical applications
Siegelman, E. S. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23601 · Cited by 40
Metastatic Adrenocortical Carcinoma: Results of 56 Pulmonary Metastasectomies in 24 Patients
den Winkel, J. O., Pfannschmidt, J., Muley, T., Grünewald, C., Dienemann, H., Faßnacht, M., & Allolio, B. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.07.088 · Cited by 40
Nelson, D. W., Chang, S., Bandera, B. C., Fischer, T. D., Wollman, R. C., & Goldfarb, M. R. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6510-x · Cited by 39
Surgical Management of Adrenocortical Carcinoma
Datta, J., & Roses, R. E. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.08.011 · Cited by 38
Curative Surgical Resection of Adrenocortical Carcinoma
Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001527 · Cited by 37
Weiss, I. D., Huff, L. M., Evbuomwan, M. O., Xu, X., Dang, H. D., Velez, D. S., SINGH, S. P., Zhang, H. H., Gardina, P. J., Lee, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19945 · Cited by 39
Metadata
- Authors
- Kebebew, E., Reiff, E., Duh, Q., Clark, O. H., & McMillan, A.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Kebebew, Electron
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2006-03-10
- Volume
- 30
- Issue
- 5
- Pages
- 872-878
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2096051245
- Cited by
- 451
- References
- 21
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 28 · 2023: 35 · 2022: 33 · 2021: 47 · 2020: 44 · 2019: 30 · 2018: 27 · 2017: 25 · 2016: 21 · 2015: 35 · 2014: 12 · 2013: 14 · 2012: 17
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- World Journal of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenal incidentaloma, adrenalectomy, tumor size, tumor grade, TNM stage, distant metastasis, surgical resection, external beam radiotherapy, cause-specific mortality, survival predictors, temporal trends in diagnosis
- MeSH terms
- Adolescent, Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Neoplasm Staging, Retrospective Studies, United States, Cohort Studies, Treatment Outcome, Adrenocortical Carcinoma, SEER Program, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review